Supreme Court rejects ‘Pharma Bro’ Martin Shkreli’s appeal of penalties

Supreme Court rejects ‘Pharma Bro’ Martin Shkreli’s appeal of penalties

The US Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli’s challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug’s price by more than 4,000%. The justices turned away Shkreli’s appeal of a lower court’s decision upholding the penalty, equal to the profits he and one of … Read more